Spectrum Pharmaceuticals, Inc. (JOBS) And Allergan Inc. (JOBS) Say FDA Gives Fast Track Status To Eoquin For Bladder Cancer

AP -- Spectrum Pharmaceuticals Inc. and Allergan Inc. said Tuesday the Food and Drug Administration will grant a faster review to their drug candidate EOquin, which is intended to treat non-muscle invasive bladder cancer.